Trifluridine/Tipiracil Combination Effective in Third and Later-Line Metastatic Gastric Cancer
This exploratory subgroup analysis of the TAGS study assessed the efficacy, safety, and quality of life (QOL) results observed in patients who received trifluridine/tipiracil or placebo in the third- or later-line settings.